← Open Payments lookup

G. MICHAEL LOPEZ: Open Payments

NPI 1003973397 · LAS VEGAS, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$564 in 26 payments from 11 companies in 2025. Trend: 2023 $342 · 2024 $408 · 2025 $564

Food & beverage: $564
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.5$173
Merck Sharp & Dohme LLC5$82
Novo Nordisk Inc4$63
AstraZeneca Pharmaceuticals LP3$57
Lilly USA, LLC2$40
Indivior Inc.2$40
Boehringer Ingelheim Pharmaceuticals, Inc.1$29
GlaxoSmithKline, LLC.1$24
Neurocrine BioSciences, Inc.1$23
Otsuka America Pharmaceutical, Inc.1$17

Products named: Kerendia, VERQUVO, MOUNJARO, SUBLOCADE, Ozempic, JARDIANCE, BREZTRI, NUCALA.

Industry payments across NM — which companies pay providers there.